Producer
AMI Life Sciences Pvt Ltd
Indian API manufacturer (Vadodara, Gujarat) with documented tapentadol API exports (Q2 2024).
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input AMI Life Sciences Pvt Ltd supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something AMI Life Sciences Pvt Ltd makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Active pharmaceutical ingredients (APIs)
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2025
Tapentadol is a genuinely dual-use molecule: a legitimate DEA Schedule II opioid analgesic (Nucynta/Palexia) and, via diversion, a driver of West Africa's opioid epidemic. Investigations found Indian firms shipped 320M+ synthetic-opioid pills (including unapproved tapentadol-carisoprodol 'Tafrodol'-type combinations) worth ~$130M to Ghana, Nigeria, Sierra Leone and neighbours over ~three years; India then moved to halt unapproved exports, and Maharashtra's FDA issued a Stop Production Order against Aveo Pharmaceuticals (Mumbai) in Feb 2025. AMI Life Sciences is a documented tapentadol-API exporter, which places it squarely in this tightly controlled, geopolitically scrutinized category — where the same active ingredient is medicine or contraband depending entirely on downstream diversion and oversight. (The named enforcement target in the reporting is Aveo, not AMI.)
NAFDAC (Nigeria) ↗Concentration2025
Controlled-substance API supply is geographically concentrated, which is exactly why one regulator's action ripples globally. India — and within it Gujarat, the country's dominant API manufacturing hub — supplies a large share of the world's small-molecule APIs, with tapentadol API made by only a small set of Indian producers. That concentration means a Stop Production Order or export ban in a single Indian state can tighten a worldwide opioid-analgesic supply chain almost overnight, affecting both legitimate pain-medicine makers and illicit diverters at the same time.
NewsOnAir (Prasar Bharati) ↗